Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that the recording is uploaded at https://indiapharma.gsk.com/en-in/investors/analyst-meets/.
The above information is a part of company’s filings submitted to BSE.